Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05415449 · ClinicalTrials.gov registry record
Exploration of Central Venous Catheter Protective Devices in the Pediatric Population: A Mixed Methods Study
A clinical trial of Central Line, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT05415449: Completed study of Central Line, sponsored by University of Texas Southwestern Medical Center.
NCT05415449 is a study of Central Line that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05415449, a study of Central Line, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
1. to determine the feasibility of utilizing a wearable device 2. to prospectively measure and evaluate parent and nurse satisfaction with the protective wearable device. This is a sequential, convergent mixed methods study design in which qualitative interview data will be collected first followed by quantitative data. Scheme and Outcomes: Identify eligible patients--Informed Consent--Provide education and two protective wearable device--Demographic data (electronic health record)--Interview parent on device--Every month complete 30-day satisfaction survey for a total of three data collection period-Discharge from study. Nurse data collection scheme: Study participants hospitalized at time of enrollment in study or anytime during the study period. Nurse of patients using device will complete satisfaction survey. Note: Vest is a Class I Exempt FDA-registered device.
Primary Outcome
No. of participants who were interviewed i.e. parents (of children using Gus gear vest) on device. Semi-structured interview guide was used to collect interview from parents. Eligible parents were parents of children between 0-12 years of age using the vest, and Parents should be able to speak English/Spanish. Interviews being qualitative in nature, the criteria to assess feasibility from parents using the vest will be done using transcription and inductive content analysis to find codes and the
Conditions Studied
Interventions
- DEVICE Gus gear protective wearable device
Study Locations (1)
Texas
- Children's Health - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-12-14 |
| Est. Completion | 2025-05-28 |
What the finished NCT05415449 record still lists
NCT05415449 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 1 condition, with Central Line appearing as the primary indexed condition, and to 1 intervention - of which Gus gear protective wearable device is the first listed.
NCT05415449 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05415449 about?
NCT05415449 is a clinical study titled "Exploration of Central Venous Catheter Protective Devices in the Pediatric Population: A Mixed Methods Study". 1. to determine the feasibility of utilizing a wearable device 2. to prospectively measure and evaluate parent and nurse satisfaction with the protective wearable device. This is a sequential, convergent mixed methods study design in which qualitative interview data will be collected first followed...
What is the current status of trial NCT05415449?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2022-12-14. Estimated completion is 2025-05-28.
What conditions does trial NCT05415449 study?
This clinical trial studies the following conditions: Central Line.
What interventions are being tested in trial NCT05415449?
The interventions under investigation include: Gus gear protective wearable device (DEVICE).
Who is sponsoring clinical trial NCT05415449?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05415449 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI